Witnessing the stock’s movement on the chart, on Wednesday, Voyager Therapeutics Inc (NASDAQ: VYGR) set off with pace as it heaved 11.63% to $5.28, before settling in for the price of $4.73 at the close. Taking a more long-term approach, VYGR posted a 52-week range of $2.64-$8.27.
The Healthcare sector firm’s twelve-monthly sales growth has been 1.48% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 1.48%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -87.10%. This publicly-traded company’s shares outstanding now amounts to $55.43 million, simultaneously with a float of $45.49 million. The organization now has a market capitalization sitting at $292.88 million. At the time of writing, stock’s 50-day Moving Average stood at $3.91, while the 200-day Moving Average is $3.93.
Voyager Therapeutics Inc (VYGR) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Voyager Therapeutics Inc’s current insider ownership accounts for 17.99%, in contrast to 60.05% institutional ownership. According to the most recent insider trade that took place on Oct 03 ’25, this organization’s Chief Financial Officer sold 7,666 shares at the rate of 4.78, making the entire transaction reach 36,643 in total value, affecting insider ownership by 123,834.
Voyager Therapeutics Inc (VYGR) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.48 per share during the current fiscal year.
Voyager Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -87.10% and is forecasted to reach -1.49 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -7.17% through the next 5 years, which can be compared against the 1.48% growth it accomplished over the previous five years trading on the market.
Voyager Therapeutics Inc (NASDAQ: VYGR) Trading Performance Indicators
Let’s observe the current performance indicators for Voyager Therapeutics Inc (VYGR). It’s Quick Ratio in the last reported quarter now stands at 5.43. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.88.
In the same vein, VYGR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.85, a figure that is expected to reach -0.52 in the next quarter, and analysts are predicting that it will be -1.49 at the market close of one year from today.
Technical Analysis of Voyager Therapeutics Inc (VYGR)
Going through the that latest performance of [Voyager Therapeutics Inc, VYGR]. Its last 5-days volume of 0.98 million indicated improvement to the volume of 0.57 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 83.05% While, its Average True Range was 73.95.
Raw Stochastic average of Voyager Therapeutics Inc (VYGR) in the period of the previous 100 days is set at 95.47%, which indicates a major rise in contrast to 91.10% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.32 that was higher than 0.25 volatility it exhibited in the past 100-days period.
